Cargando…
Central injection of fibroblast growth factor 1 induces sustained remission of diabetic hyperglycemia in rodents
Type 2 diabetes (T2D) is among the most common and costly disorders worldwide(1). The goal of current medical management of T2D is to transiently ameliorate hyperglycemia through daily dosing of one or more anti-diabetic drugs. Hypoglycemia and weight are common side effects of therapy, and sustaine...
Autores principales: | Scarlett, Jarrad M., Rojas, Jennifer M., Matsen, Miles E., Kaiyala, Karl J., Stefanovski, Darko, Bergman, Richard N., Nguyen, Hong T., Dorfman, Mauricio D., Lantier, Louise, Wasserman, David H., Mirzadeh, Zaman, Unterman, Terry G., Morton, Gregory J., Schwartz, Michael W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4938755/ https://www.ncbi.nlm.nih.gov/pubmed/27213816 http://dx.doi.org/10.1038/nm.4101 |
Ejemplares similares
-
Glucose intolerance induced by blockade of central FGF receptors is linked to an acute stress response
por: Rojas, Jennifer M., et al.
Publicado: (2015) -
Peripheral Mechanisms Mediating the Sustained Antidiabetic Action of FGF1 in the Brain
por: Scarlett, Jarrad M., et al.
Publicado: (2019) -
Hypothalamic perineuronal net assembly is required for sustained diabetes remission induced by fibroblast growth factor 1 in rats
por: Alonge, Kimberly M., et al.
Publicado: (2020) -
Evidence That in Uncontrolled Diabetes, Hyperglucagonemia Is Required for Ketosis but Not for Increased Hepatic Glucose Production or Hyperglycemia
por: Meek, Thomas H., et al.
Publicado: (2015) -
Role of hypothalamic MAPK/ERK signaling and central action of FGF1 in diabetes remission
por: Brown, Jenny M., et al.
Publicado: (2021)